Thursday, August 26th, 2010
Researchers from the University of Western Australia and Sir Charles Gairdner Hospital have further confirmed that higher levels of a particular protein, serum mesothelin, are found in patients with asbestos-related cancer.
Their research has encouraged the use of screening tests such as the MESOMARK
